Difference between revisions of "Osocimab (BAY-1213790)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "==Mechanism of action== Anti-Factor XIa antibody ==Preliminary data== ===Venous thromboembolism=== # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freita...")
(No difference)

Revision as of 03:19, 31 January 2020

Mechanism of action

Anti-Factor XIa antibody

Preliminary data

Venous thromboembolism

  1. FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article PubMed